11-108249105-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_000051.4(ATM):c.1235+3A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00000248 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000051.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.1235+3A>G | splice_region_variant, intron_variant | Intron 9 of 62 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 251020Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135678
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461540Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727090
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:3
This variant causes an A to G nucleotide substitution at the +3 position of intron 9 of the ATM gene. Splice site prediction tools suggest that this variant may have a significant impact on RNA splicing. An RNA study has detected the out-of-frame skipping of exon 9 in RNA from a heterozygous carrier (PMID: 31403082), although the completeness of the splicing defect was not determined. This variant has been reported in two siblings affected with adult-onset and mild ataxia telangiectasia with an ATM pathogenic covariant, c.6205C>T (p.Gln2069*) (PMID: 31403082). There is no personal and family history of cancer reported in this case study (PMID: 31403082). This variant has been identified in 2/251020 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Although there is a suspicion that this variant may be associated with disease, additional functional and clinical studies are necessary to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
The c.1235+3A>G intronic variant results from an A to G substitution 3 nucleotides after coding exon 8 in the ATM gene. This nucleotide position is highly conserved in available vertebrate species. This alteration was identified in conjunction with another ATM alteration (c.6205C>T, p.Gln2069*) in a patient diagnosed with adult-onset, variant ataxia-telangiectasia (Krenn M et al. Neurol Genet. 2019 Aug;5:e346). In silico splice site analysis predicts that this alteration will weaken the native splice donor site; however, direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
- -
Ataxia-telangiectasia syndrome Pathogenic:2
This sequence change falls in intron 9 of the ATM gene. It does not directly change the encoded amino acid sequence of the ATM protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has been observed in individual(s) with autosomal recessive ataxia-telangiectasia (PMID: 31403082). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 482570). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 9, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 31403082; internal data). For these reasons, this variant has been classified as Pathogenic. -
- -
Ataxia-telangiectasia syndrome;C0346153:Familial cancer of breast Pathogenic:1
- -
not provided Pathogenic:1
Non-canonical splice site variant demonstrated to result in exon skipping (Krenn et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); Observed with a second pathogenic ATM variant (phase unknown) in two siblings with adult-onset ataxia, nystagmus, and dysarthria (Krenn et al., 2019); This variant is associated with the following publications: (PMID: 31403082, Zureick2023[Article]) -
Familial cancer of breast Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at